Trimb Healthcare has acquired a portfolio of European OTC products from Cilag GmbH International and Janssen Pharmaceutica NV.
The products, which include Pevaryl, Fungoral, Gyno-Pevaryl and Epi-Pevaryl, are based on the anti-fungal substances econazole and ketoconazole and are used to treat common fungal infections of the skin. The acquired territory includes Sweden, Norway, Germany, Switzerland, Austria and other European countries.
“This deal with J&J is an important step for Trimb and we continue to strengthen our OTC position in northern Europe. We also strengthen our position in dermatology and we see good synergies with Trimb’s other anti-fungal brands, e.g. Cortimyk and Nailner”, said Magnus Kamryd, CEO of Trimb.